Tebas P - Search Results

1

Aging and HIV infection: a comparison between older HIV-infected persons and the general population.

Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, Tebas P. Onen NF, et al. Among authors: tebas p. HIV Clin Trials. 2010 Mar-Apr;11(2):100-9. doi: 10.1310/hct1102-100. HIV Clin Trials. 2010. PMID: 20542846

2

Emerging bone problems in patients infected with human immunodeficiency virus.

Mondy K, Tebas P. Mondy K, et al. Among authors: tebas p. Clin Infect Dis. 2003 Apr 1;36(Suppl 2):S101-5. doi: 10.1086/367566. Clin Infect Dis. 2003. PMID: 12652379

3

Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies.

Tebas P, Henry K, Mondy K, Deeks S, Valdez H, Cohen C, Powderly WG. Tebas P, et al. J Infect Dis. 2002 Sep 15;186(6):851-4. doi: 10.1086/342603. Epub 2002 Aug 28. J Infect Dis. 2002. PMID: 12198623

4

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P. Mondy K, et al. Among authors: tebas p. Clin Infect Dis. 2003 Feb 15;36(4):482-90. doi: 10.1086/367569. Epub 2003 Jan 29. Clin Infect Dis. 2003. PMID: 12567307

5

Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.

Mondy K, Powderly WG, Claxton SA, Yarasheski KH, Royal M, Stoneman JS, Hoffmann ME, Tebas P. Mondy K, et al. Among authors: tebas p. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):426-31. doi: 10.1097/01.qai.0000145352.04440.1e. J Acquir Immune Defic Syndr. 2005. PMID: 15764959 Clinical Trial.

6

Cardiovascular risks of antiretroviral therapies.

Mondy K, Tebas P. Mondy K, et al. Among authors: tebas p. Annu Rev Med. 2007;58:141-55. doi: 10.1146/annurev.med.58.072905.180040. Annu Rev Med. 2007. PMID: 17217329 Review.

7

Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT. McComsey GA, et al. Among authors: tebas p. Clin Infect Dis. 2010 Oct 15;51(8):937-46. doi: 10.1086/656412. Clin Infect Dis. 2010. PMID: 20839968 Free PMC article. Review.

8

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial.

Overton ET, Tebas P, Coate B, Ryan R, Perniciaro A, Dayaram YK, De La Rosa G, Baugh BP. Overton ET, et al. Among authors: tebas p. HIV Clin Trials. 2016 Mar;17(2):72-7. doi: 10.1080/15284336.2016.1141468. HIV Clin Trials. 2016. PMID: 26917112 Free PMC article. Clinical Trial.

9

Nonnucleoside reverse transcriptase inhibitor resistance among antiretroviral-naive HIV-positive pregnant women.

Juethner SN, Williamson C, Ristig MB, Tebas P, Seyfried W, Aberg JA. Juethner SN, et al. Among authors: tebas p. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):153-6. doi: 10.1097/00126334-200302010-00006. J Acquir Immune Defic Syndr. 2003. PMID: 12571524

10

Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy.

Gerber MT, Mondy KE, Yarasheski KE, Drechsler H, Claxton S, Stoneman J, DeMarco D, Powderly WG, Tebas P. Gerber MT, et al. Among authors: tebas p. Clin Infect Dis. 2004 Aug 1;39(3):419-25. doi: 10.1086/422144. Epub 2004 Jul 16. Clin Infect Dis. 2004. PMID: 15307011 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page